The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC) (2018)
- Authors:
- Autor USP: CHAMMAS, ROGER - FM
- Unidade: FM
- DOI: 10.1590/1414-431X20177214
- Subjects: ANTINEOPLÁSICOS; BIOFARMACOLOGIA; NEOPLASIAS; ANTICORPOS; FÁRMACOS IMUNOSSUPRESSORES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian journal of medical and biological research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: v. 51, n. 3, article ID e7214, 7p, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FERNANDES, G. S. et al. The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC). Brazilian journal of medical and biological research, v. 51, n. 3, 2018Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20177214. Acesso em: 30 mar. 2024. -
APA
Fernandes, G. S., Sternberg, C., Lopes, G., Chammas, R., Gifone, M. A. C., Gil, R. A., & Araujo, D. V. (2018). The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC). Brazilian journal of medical and biological research, 51( 3). doi:10.1590/1414-431X20177214 -
NLM
Fernandes GS, Sternberg C, Lopes G, Chammas R, Gifone MAC, Gil RA, Araujo DV. The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC) [Internet]. Brazilian journal of medical and biological research. 2018 ; 51( 3):[citado 2024 mar. 30 ] Available from: https://doi.org/10.1590/1414-431X20177214 -
Vancouver
Fernandes GS, Sternberg C, Lopes G, Chammas R, Gifone MAC, Gil RA, Araujo DV. The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC) [Internet]. Brazilian journal of medical and biological research. 2018 ; 51( 3):[citado 2024 mar. 30 ] Available from: https://doi.org/10.1590/1414-431X20177214 - Princípios e classificações da terapia antineoplásica
- Conserved cysteines in the sialytransferase sialylmotifs form an essential disulfide bond
- Cell adhesion inhibition by an ARG-GLY-ASP containing peptide based on a trypsin inhibitor isolated from bauhinia rufa
- Apoptosis induced by selectable marker gene bsrm
- Use of RNA interference to investigate ADAM23 function and its role breast cancer progression
- Sinalização celular de células eucarióticas
- NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis
- Clinical implication of 14-3-3 epsilon expression in gastric cancer
- The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3-/- mice
- A novel tool for the assessment of galectin-3 ligands
Informações sobre o DOI: 10.1590/1414-431X20177214 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas